BLACKROCK HEALTH SCIENCES TR's ticker is BME and the CUSIP is 09250W107. A total of 38 filers reported holding BLACKROCK HEALTH SCIENCES TR in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $1,049,000 | -2.6% | 26,981 | -0.3% | 0.04% | -2.7% |
| Q1 2019 | $1,077,000 | -0.9% | 27,067 | -9.3% | 0.04% | -14.0% |
| Q4 2018 | $1,087,000 | -19.7% | 29,846 | -6.1% | 0.04% | -6.5% |
| Q3 2018 | $1,353,000 | +9.1% | 31,784 | -1.3% | 0.05% | -2.1% |
| Q2 2018 | $1,240,000 | +3.9% | 32,193 | -5.8% | 0.05% | +2.2% |
| Q1 2018 | $1,194,000 | -2.1% | 34,191 | +2.1% | 0.05% | -6.1% |
| Q4 2017 | $1,220,000 | +4.8% | 33,503 | +4.8% | 0.05% | -2.0% |
| Q3 2017 | $1,164,000 | +1.0% | 31,962 | +1.5% | 0.05% | -2.0% |
| Q2 2017 | $1,153,000 | +25.7% | 31,503 | +18.9% | 0.05% | +8.5% |
| Q1 2017 | $917,000 | +53.9% | 26,498 | +41.0% | 0.05% | +56.7% |
| Q4 2016 | $596,000 | +16.6% | 18,787 | +26.4% | 0.03% | +11.1% |
| Q3 2016 | $511,000 | -22.5% | 14,866 | -19.5% | 0.03% | -27.0% |
| Q2 2016 | $659,000 | +99.7% | 18,467 | +99.9% | 0.04% | +105.6% |
| Q1 2016 | $330,000 | +44.1% | 9,236 | +59.2% | 0.02% | +50.0% |
| Q4 2015 | $229,000 | – | 5,803 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RENAISSANCE INVESTMENT CONSULTANTS HOLDING COMPANY, LLC | 18,736 | $675,000 | 0.94% |
| CORRADO ADVISORS, LLC | 9,565 | $344,000 | 0.32% |
| Rikoon Group, LLC | 19,188 | $692,000 | 0.29% |
| Eudaimonia Partners, LLC | 4,875 | $176,000 | 0.08% |
| Arete Wealth Advisors, LLC | 10,183 | $367,000 | 0.07% |
| CENTAURUS FINANCIAL, INC. | 8,465 | $305,000 | 0.06% |
| Cetera Advisors LLC | 17,379 | $627,000 | 0.03% |
| Jacobi Capital Management LLC | 4,034 | $145,000 | 0.03% |
| Financial Advantage, Inc. | 773 | $27,000 | 0.02% |
| MID ATLANTIC FINANCIAL MANAGEMENT INC/ADV | 5,868 | $212,000 | 0.02% |